Ocular Therapeutix, Inc.
DE ˙ DB ˙ US67576A1007
7,15 € ↑0,25 (3,62%)
2026-06-04
DEL PRIS
SecurityDE:0OT / Ocular Therapeutix, Inc.
InstitutionNorthern Trust Corp
Latest Disclosed Ownership1,525,626 shares
Latest Disclosed Value $ 12,922,052
Northern Trust Corp reports 4.32% increase in ownership of 0OT / Ocular Therapeutix, Inc.

On May 14, 2026 - Northern Trust Corp filed a 13F-HR form disclosing ownership of 1,525,626 shares of Ocular Therapeutix, Inc. (DE:0OT) valued at $10,136,259 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 1,462,503 shares of Ocular Therapeutix, Inc.. This represents a change in shares of 4.32% during the quarter. The current value of the position is $10,908,226 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,525,626 63,123 4.32 12,922 -27.22 0.0004
2026-02-17 2025-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,462,503 287,169 24.43 17,755 29.22 0.0023
2025-11-14 2025-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,175,334 19,076 1.65 13,740 28.04 0.0018
2025-08-13 2025-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,156,258 -134,659 -10.43 10,730 13.40 0.0015
2025-05-13 2025-03-31 13F OCULAR THERAPEUTIX COM 67576A100 1,290,917 -23,954 -1.82 9,462 -15.73 0.0014
2025-02-14 2024-12-31 13F OCULAR THERAPEUTIX COM 67576A100 1,314,871 68,174 5.47 11,229 3.52 0.0016
2024-11-13 2024-09-30 13F OCULAR THERAPEUTIX COM 67576A100 1,246,697 167,420 15.51 10,846 46.92 0.0018
2024-08-14 2024-06-30 13F OCULAR THERAPEUTIX COM 67576A100 1,079,277 109,179 11.25 7,382 -16.37 0.0012
2024-05-14 2024-03-31 13F OCULAR THERAPEUTIX COM 67576A100 970,098 298,114 44.36 8,828 194.53 0.0015
2024-02-13 2023-12-31 13F OCULAR THERAPEUTIX COM 67576A100 671,984 -1,752 -0.26 2,997 41.70 0.0005
2023-11-13 2023-09-30 13F OCULAR THERAPEUTIX COM 67576A100 673,736 11,226 1.69 2,116 -38.12 0.0004
2023-08-11 2023-06-30 13F OCULAR THERAPEUTIX COM 67576A100 662,510 5,413 0.82 3,419 -1.27 0.0007
2023-05-15 2023-03-31 13F OCULAR THERAPEUTIX COM 67576A100 657,097 1,441 0.22 3,463 87.95 0.0007
2023-02-13 2022-12-31 13F OCULAR THERAPEUTIX COM 67576A100 655,656 2,779 0.43 1,842 -32.03 0.0004
2022-11-14 2022-09-30 13F OCULAR THERAPEUTIX COM 67576A100 652,877 -14,704 -2.20 2,710 0.97 0.0006
2022-08-12 2022-06-30 13F OCULAR THERAPEUTIX COM 67576A100 667,581 -61,579 -8.45 2,684 -25.63 0.0006
2022-05-13 2022-03-31 13F OCULAR THERAPEUTIX COM 67576A100 729,160 -35,817 -4.68 3,609 -32.30 0.0006
2022-02-08 2021-12-31 13F OCULAR THERAPEUTIX COM 67576A100 764,977 19,477 2.61 5,331 -28.50 0.0009
2021-11-15 2021-09-30 13F OCULAR THERAPEUTIX COM 67576A100 745,500 -44,121 -5.59 7,456 -33.42 0.0013
2021-08-13 2021-06-30 13F OCULAR THERAPEUTIX COM 67576A100 789,621 677 0.09 11,198 -13.50 0.0020
2021-05-12 2021-03-31 13F OCULAR THERAPEUTIX COM 67576A100 788,944 7,374 0.94 12,946 -19.98 0.0024
2021-02-11 2020-12-31 13F OCULAR THERAPEUTIX COM 67576A100 781,570 99,581 14.60 16,178 211.71 0.0032
2020-11-16 2020-09-30 13F OCULAR THERAPEUTIX COM 67576A100 681,989 37,034 5.74 5,190 -3.41 0.0011
2020-08-14 2020-06-30 13F OCULAR THERAPEUTIX COM 67576A100 644,955 128,854 24.97 5,373 110.29 0.0013
2020-05-14 2020-03-31 13F OCULAR THERAPEUTIX COM 67576A100 516,101 38,718 8.11 2,555 35.54 0.0007
2020-02-14 2019-12-31 13F OCULAR THERAPEUTIX COM 67576A100 477,383 -10,040 -2.06 1,885 27.19 0.0004
2019-11-13 2019-09-30 13F OCULAR THERAPEUTIX COM 67576A100 487,423 67,441 16.06 1,482 -19.81 0.0004
2019-08-13 2019-06-30 13F OCULAR THERAPEUTIX COM 67576A100 419,982 13,249 3.26 1,848 14.43 0.0004
2019-05-13 2019-03-31 13F OCULAR THERAPEUTIX COM 67576A100 406,733 3,291 0.82 1,615 0.56 0.0004
2019-02-12 2018-12-31 13F OCULAR THERAPEUTIX COM 67576A100 403,442 14,493 3.73 1,606 -39.99 0.0005
2018-11-14 2018-09-30 13F OCULAR THERAPEUTIX COM 67576A100 388,949 26,322 7.26 2,676 9.36 0.0007
2018-09-18 2018-06-30 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 362,627 38,101 11.74 2,447 15.86 0.0006
2018-08-14 2018-06-30 13F OCULAR THERAPEUTIX COM 67576A100 362,627 38,101 2,447
2018-05-09 2018-03-31 13F OCULAR THERAPEUTIX COM 67576A100 324,526 62,993 24.09 2,112 81.44 0.0005
2018-02-14 2017-12-31 13F OCULAR THERAPEUTIX COM 67576A100 261,533 -868 -0.33 1,164 -28.24 0.0003
2017-11-13 2017-09-30 13F OCULAR THERAPEUTIX COM 67576A100 262,401 262 0.10 1,622 -33.25 0.0004
2017-08-11 2017-06-30 13F OCULAR THERAPEUTIX COM 67576A100 262,139 30,539 13.19 2,430 13.08 0.0007
2017-05-12 2017-03-31 13F OCULAR THERAPEUTIX COM 67576A100 231,600 32,160 16.13 2,149 28.68 0.0006
2017-02-13 2016-12-31 13F OCULAR THERAPEUTIX COM 67576A100 199,440 -10,905 -5.18 1,670 15.57 0.0005
2016-11-09 2016-09-30 13F OCULAR THERAPEUTIX COM 67576A100 210,345 16,541 8.53 1,445 50.68 0.0005
2016-08-12 2016-06-30 13F OCULAR THERAPEUTIX COM 67576A100 193,804 30,755 18.86 959 -39.11 0.0003
2016-08-19 2016-03-31 13F/A-1 OCULAR THERAPEUTIX COM 67576A100 163,049 281 0.17 1,575 3.28 0.0005
2016-05-13 2016-03-31 13F OCULAR THERAPEUTIX COM 67576A100 163,049 1,575
2016-02-12 2015-12-31 13F OCULAR THERAPEUTIX COM 67576A100 162,768 6,292 4.02 1,525 -30.68 0.0005
2015-11-12 2015-09-30 13F OCULAR THERAPEUTIX COM 67576A100 156,476 156,476 0.00 2,200 0.0007
2015-08-13 2015-06-30 13F OCULAR THERAPEUTIX COM 67576A100 0 -58,470 -100.00 0 -100.00
2015-05-14 2015-03-31 13F OCULAR THERAPEUTIX COM 67576A100 58,470 86 0.15 2,455 78.81 0.0007
2015-02-12 2014-12-31 13F OCULAR THERAPEUTIX COM 67576A100 58,384 47,161 420.22 1,373 717.26 0.0004
2014-11-13 2014-09-30 13F OCULAR THERAPEUTIX COM 67576A100 11,223 11,223 168 0.0001
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.